Centre Paul Strauss
Clinical trials sponsored by Centre Paul Strauss, explained in plain language.
-
Brain cancer boost: new PET-Guided radiation aims to outsmart glioblastoma
Disease control Recruiting nowThis study tests a higher radiation dose for frail adults with glioblastoma who cannot have standard surgery. The extra dose is aimed at the most aggressive tumor areas, identified by a special FDOPA PET scan. The goal is to see if this approach can help people live longer. About…
Phase: PHASE2 • Sponsor: Centre Paul Strauss • Aim: Disease control
Last updated May 26, 2026 05:05 UTC
-
New hope for head & neck cancer: Triple-Drug combo tested after immunotherapy fails
Disease control Recruiting nowThis study tests a combination of three drugs (carboplatin, paclitaxel, and cetuximab) in adults with head and neck cancer that has spread or returned and did not respond to first-line immunotherapy. The goal is to see if this second-line treatment can shrink tumors and control t…
Phase: PHASE2 • Sponsor: Centre Paul Strauss • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
15,000 volunteers join fight to stop deadly gallbladder cancer before it starts
Prevention Recruiting nowThis study aims to prevent gallbladder cancer by identifying who is most at risk. Researchers will follow 15,000 people with gallstones or gallbladder cancer to find genetic and environmental markers in blood, saliva, and other samples. The goal is to develop better prediction an…
Sponsor: Centre Paul Strauss • Aim: Prevention
Last updated May 26, 2026 05:02 UTC
-
Team approach may help seniors beat chemo hurdles
Symptom relief Recruiting nowThis study looks at whether a special team of doctors, nurses, and other experts can help people aged 75 and older with digestive cancer complete their full course of chemotherapy or targeted therapy. The program starts early and focuses on managing side effects and overall well-…
Phase: NA • Sponsor: Centre Paul Strauss • Aim: Symptom relief
Last updated May 26, 2026 05:03 UTC
-
Pedaling through chemo: cycling program aims to keep breast cancer patients strong
Symptom relief Recruiting nowThis study tests whether a 15-week cycling program (one session per week) can help breast cancer patients maintain their physical fitness during chemotherapy. The trial will include 156 women with early-stage breast cancer who are receiving a common chemo combination. Half will d…
Phase: NA • Sponsor: Centre Paul Strauss • Aim: Symptom relief
Last updated May 26, 2026 05:03 UTC
-
Horses help kids cope with cancer radiation
Symptom relief Recruiting nowThis study looks at whether spending time with horses can improve quality of life and reduce anxiety in children and teens (ages 8 to 17) who are receiving radiation therapy for cancer. About 22 participants will take part in horse-assisted therapy sessions alongside their regula…
Phase: NA • Sponsor: Centre Paul Strauss • Aim: Symptom relief
Last updated May 26, 2026 04:37 UTC
-
Chemotherapy's hidden toll on nerve reflexes revealed
Knowledge-focused Recruiting nowThis study looks at how chemotherapy changes certain nerve reflexes that control blood pressure and exercise response in breast cancer patients. Researchers will compare 24 women who recently finished chemotherapy with healthy women of similar age and fitness. The goal is to unde…
Phase: NA • Sponsor: Centre Paul Strauss • Aim: Knowledge-focused
Last updated May 26, 2026 05:10 UTC
-
New imaging tool could sharpen cervical cancer staging
Knowledge-focused Recruiting nowThis study tests whether a newer type of scan, PET/MRI, is better than the standard PET/CT at finding cancer spread to lymph nodes in people with locally advanced cervical cancer. About 50 adults with stage IB2 to IVA cervical cancer will receive both scans before treatment. The …
Sponsor: Centre Paul Strauss • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC
-
New study aims to predict chemo heart risks in breast cancer patients
Knowledge-focused Recruiting nowThis study looks at whether a protein called SGLT2 can help identify breast cancer patients at higher risk for heart damage from a common chemotherapy drug (anthracycline). Researchers will measure SGLT2 levels in blood and cells before and after treatment. The goal is to better …
Sponsor: Centre Paul Strauss • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC
-
New MRI method reveals hidden clues in brain tumors
Knowledge-focused Recruiting nowThis study is testing a new MRI technique called CEST to create detailed maps of acidity (pH) inside brain tumors like gliomas and metastases. Researchers will scan 800 patients to see if pH levels can help predict where tumors might return or how long patients survive. The goal …
Phase: NA • Sponsor: Centre Paul Strauss • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC
-
PET scans may sharpen radiation for returning brain tumors
Knowledge-focused Recruiting nowThis study tests whether using a special PET scan (FDOPA-PET) to guide radiation therapy can help people with recurrent glioblastoma, an aggressive brain cancer. About 54 adults whose tumor has come back after prior radiation will receive targeted radiation based on the PET scan.…
Phase: PHASE2 • Sponsor: Centre Paul Strauss • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC